Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein
Efforts to develop a vaccine for respiratory syncytial virus (RSV) have primarily focused on the RSV fusion protein. The pre-fusion conformation of this protein induces the most potent neutralizing antibodies and is the focus of recent efforts in vaccine development. Following the first identificati...
Main Authors: | Lori M. Cullen, Madelyn R. Schmidt, Gretel M. Torres, Adam A. Capoferri, Trudy G. Morrison |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/7/1/21 |
Similar Items
-
Two RSV Platforms for G, F, or G+F Proteins VLPs
by: Binh Ha, et al.
Published: (2020-08-01) -
Current Insights in the Development of Efficacious Vaccines Against RSV
by: Jorge A. Soto, et al.
Published: (2020-07-01) -
Identification and Characterization of Essential Residues at the Apex of the RSV FusionProtein
by: Hicks, Stephanie
Published: (2018) -
Comparisons of Antibody Populations in Different Pre-Fusion F VLP-Immunized Cotton Rat Dams and Their Offspring
by: Lori M. Cullen, et al.
Published: (2020-03-01) -
Novel intranasal proteosome-based respiratory syncytial virus (RSV) vaccines elicit protection in mice without the risk of enhanced pathology or eosinophila by triggering innate immune pathways
by: Cyr, Sonya L.
Published: (2007)